Literature DB >> 9681823

Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells.

D Marchetti1, N Parikh, M Sudol, G E Gallick.   

Abstract

The c-Yes proto-oncogene (pp62c-Yes) encodes a non-receptor-type protein tyrosine kinase (NRPTK) of the Src family. c-Yes activities and protein levels are elevated in human melanoma and melanocyte cell lines. Because the neurotrophins (NT) are important in the progression of melanoma to the brain-metastatic phenotype, we determined whether NT stimulate c-Yes activity in human MeWo melanoma cells and two variant sublines with opposite metastatic capabilities, 3 S 5 and 70W. The highly brain-metastatic 70W subline had an intrinsically higher c-Yes activity than parental MeWo or poorly metastatic 3 S 5 cells. c-Yes kinase was further induced by the prototypic human NT, nerve growth factor (NGF) in a dose and time-dependent manner. In contrast, c-Src activity (pp60-Src) was similar in all these cells and unaffected by NGF exposure. Additionally, human NGF and neurotrophin-3 stimulated c-Yes in brain-metastatic 70W cells. The magnitude of c-Yes activation correlated with the degree of invasion of 70 W cells following incubation of these neurotrophins. To further examine NT stimulation of c-Yes in melanoma cells, three additional cell lines were examined. Metastatic TXM-13 and TXM-18 increased c-Yes activity in response to NGF. In contrast, no increase was observed in low-metastatic TXM-40 cells. Together, these data suggest that altered c-Yes expression may play a role in the malignant progression of the human melanocyte towards the brain-metastatic phenotype and that NT enhance the activity of c-Yes in signaling penetration into the matrix of NT-rich stromal microenvironments such as the brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681823     DOI: 10.1038/sj.onc.1201877

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

Authors:  Wenjin Liu; Kimberly B Monahan; Adam D Pfefferle; Takeshi Shimamura; Jessica Sorrentino; Keefe T Chan; David W Roadcap; David W Ollila; Nancy E Thomas; Diego H Castrillon; C Ryan Miller; Charles M Perou; Kwok-Kin Wong; James E Bear; Norman E Sharpless
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

2.  Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells.

Authors:  E T Walch; D Marchetti
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

3.  Functional activation of Src family kinase yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3.

Authors:  Kazunori Hamamura; Momoko Tsuji; Hiroshi Hotta; Yuki Ohkawa; Masataka Takahashi; Hidenobu Shibuya; Hideyuki Nakashima; Yoshio Yamauchi; Noboru Hashimoto; Hisashi Hattori; Minoru Ueda; Keiko Furukawa; Koichi Furukawa
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

Review 4.  Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies.

Authors:  Manmeet S Ahluwalia; John de Groot; Wei Michael Liu; Candece L Gladson
Journal:  Cancer Lett       Date:  2010-12-08       Impact factor: 8.679

5.  Expression of N-myristoyltransferase in human brain tumors.

Authors:  Yanjie Lu; Ponniah Selvakumar; Kaiser Ali; Anuraag Shrivastav; Gagan Bajaj; Lothar Resch; Robert Griebel; Daryl Fourney; Kotoo Meguro; Rajendra K Sharma
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

6.  Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors.

Authors:  Samir D Undevia; Nicholas J Vogelzang; Ann M Mauer; Linda Janisch; Sridhar Mani; Mark J Ratain
Journal:  Invest New Drugs       Date:  2004-11       Impact factor: 3.850

7.  A Fyn biosensor reveals pulsatile, spatially localized kinase activity and signaling crosstalk in live mammalian cells.

Authors:  Ananya Mukherjee; Randhir Singh; Sreeram Udayan; Sayan Biswas; Pothula Purushotham Reddy; Saumya Manmadhan; Geen George; Shilpa Kumar; Ranabir Das; Balaji M Rao; Akash Gulyani
Journal:  Elife       Date:  2020-02-04       Impact factor: 8.140

8.  Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas.

Authors:  Antonio Chiaretti; Luigi Aloe; Alessia Antonelli; Antonio Ruggiero; Marco Piastra; Riccardo Riccardi; Giampiero Tamburrini; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2004-05-06       Impact factor: 1.475

9.  Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration.

Authors:  Sijo Mathew; Sudeep P George; Yaohong Wang; Mohammad Rizwan Siddiqui; Kamalakkannan Srinivasan; Langzhu Tan; Seema Khurana
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

10.  A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling.

Authors:  Maddalena Cross; Xavier F Csar; Nicholas J Wilson; Gaël Manes; Theresa A Addona; Denese C Marks; Genevieve A Whitty; Keith Ashman; John A Hamilton
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.